Skip to main content
. 2013 May 10;18(5):558–567. doi: 10.1634/theoncologist.2012-0478

Figure 1.

Figure 1.

Treatment algorithm for patients with metastatic castration-resistant prostate cancer who relapse after 6–8 cycles of docetaxel. Asterisks indicate treatment options that are affected by funding and availability in some countries.

Abbreviations: mCRPC, metastatic castration-resistant prostate cancer; PSA DT, prostate-specific antigen doubling time.